- Home
- ATAI
as 11-20-2024 4:00pm EST
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
| Founded: | 2018 | Country: | Germany |
| Employees: | N/A | City: | BERLIN |
| Market Cap: | 214.8M | IPO Year: | 2021 |
| Target Price: | $9.00 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.80 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.02 - $2.85 | Next Earning Date: | 11-13-2024 |
| Revenue: | $331,000 | Revenue Growth: | -0.90% |
| Revenue Growth (this year): | 44.72% | Revenue Growth (next year): | -32.66% |
Latest ATAI Life Sciences N.V. News
ATAI Breaking Stock News: Dive into ATAI Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
Oxbridge Re Holdings Among 3 US Penny Stocks To Watch
GlobeNewswire
8 days ago
atai Life Sciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
10 days ago
Altimmune Appoints Life Sciences Industry Veteran Greg Weaver as Chief Financial Officer
Simply Wall St.
a month ago
374Water And 2 Other Promising US Penny Stocks To Watch
GlobeNewswire
a month ago
atai Life Sciences to Participate in the 2024 Maxim Healthcare Virtual Summit
GlobeNewswire
3 months ago
atai Life Sciences to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewswire
3 months ago
atai Life Sciences Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
3 months ago
atai Life Sciences Announces Positive Preliminary Results from Phase 1b Trial of VLS-01 (Buccal Film DMT)
Compare ATAI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ATAI ATAI Life Sciences N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.